Free Trial

Michael Weinstein Analyst Performance

Analyst at JPMorgan Chase & Co.

Michael Weinstein is a stock analyst at JPMorgan Chase & Co. in the medical sector, covering 7 publicly traded companies. Over the past year, Michael Weinstein has issued 1 stock ratings, including and hold recommendations. While full access to Michael Weinstein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Weinstein's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
24 Last 11 Years
Buy Recommendations
66.67% 16 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%16 ratings
Hold33.3%8 ratings
Sell0.0%0 ratings

Out of 24 total stock ratings issued by Michael Weinstein at JPMorgan Chase & Co., the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
85.7% of companies on NYSE
6 companies
NASDAQ
14.3% of companies on NASDAQ
1 company

Michael Weinstein, an analyst at JPMorgan Chase & Co., currently covers 7 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
7 companies
100.0%

Michael Weinstein of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
3 companies
42.9%
MED INSTRUMENTS
2 companies
28.6%
LARGE CAP PHARMA
1 company
14.3%
MED/DENTAL - SUPP
1 company
14.3%

Michael Weinstein's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
9/16/2025Boost Price Target$176.48$200.00Neutral